Colorectal Cancer Clinical Trial
Official title:
Preventive Strategies in Colorectal Carcinogenesis Production and Meat Processing
Colorectal Cancer is, in non-smokers for both sex, first cause of cancers mortality in
Western country.
The main risk factors associated with colorectal cancer depend of lifestyle, and processed
meat and red meat could be involved in carcinogenesis by cytotoxic and genotoxic compound
linked to lipid peroxidation and nitrosation.
The aim of this study is to study the impact of the daily consumption of beef, processed or
not, on lipid peroxidation induced heme iron ; and to study the impact of the daily
consumption of ham, processed or not, on the nitrosilation induced heme iron.
Status | Completed |
Enrollment | 24 |
Est. completion date | July 2014 |
Est. primary completion date | July 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 40 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Male - Body mass index 20 <= BMI <= 30 kg/m2 - Affiliated to French National Health Insurance - Subject giving his written informed consent - Subject considered as normal after clinical examination and medical questionnaire Exclusion Criteria: - Previous medical and/or surgery judged by the investigator as incompatible with this study - Previous familial of colon, ovarian or breast cancer - Chronic pathologies : cardiovascular diseases, cancer, chronic inflammation diseases, renal, intestinal impairments - Dislike ham or red meat - Heavy consumer of alcohol - Practising intensive physical exercise (> 5 hours) - Being under someone's supervision - Refusal to be registered on the National Volunteers Data file - Dietary habits unreliable to controlled food intake - Being in exclusion on the National Volunteers Data file |
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science
Country | Name | City | State |
---|---|---|---|
France | CRNH Auvergne | Clermont-Ferrand | Auvergne |
Lead Sponsor | Collaborator |
---|---|
Institut National de la Recherche Agronomique | Centre de Recherche en Nutrition Humaine d'Auvergne |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Fecal marker | TBARS Fecal for red meat pane and NOCs Fecal for ham | 12 weeks | No |
Secondary | NOC | Fecal marker for red meat pane | 12 weeks | No |
Secondary | cytotoxic activity of fecal water | Fecal marker for red meat pane | 12 weeks | No |
Secondary | DHN-MA | urinary marker for red meat pane | 12 weeks | No |
Secondary | TBARs | Fecal marker for ham | 12 weeks | No |
Secondary | cytotoxic activity of fecal water | Fecal marker for ham | 12 weeks | No |
Secondary | DHN-MA | urinary marker for ham | 12 weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |